Despite a decade of tightly regulating testing, the FDA is now allowing companies to proceed with their diagnostic tests for COVID-19 without first submitting them for federal review or obtaining an official emergency clearance. In the past, the FDA has warned of the personal health risks that could follow

   EDITOR’s NOTE: Longtime health reporter Charles Ornstein says that comparing the novel coronavirus to the flu is dangerously inaccurate. Not one public health expert he trusts has called that comparison valid. Here’s why. by Charles Ornstein   Is the United States Prepared for COVID-19? As a longtime health care

  Based on current understanding of risk, forty-one percent of adults ages 18 and older in the U.S. have a higher risk of developing more serious illness if they become infected with the virus that causes COVID-19, because they are older or have serious underlying health conditions, or both, according

  The Trump Administration announced on March 12 aggressive actions and regulatory flexibilities to help healthcare providers and states respond to and contain the spread of 2019 Novel Coronavirus Disease (COVID-19). The Centers for Medicare & Medicaid Services (CMS) is taking these actions following President Trump’s declaration of a national

    Thrombolex Inc., a medical device company focused on the design, development and manufacture of endovascular therapies for the treatment of arterial and venous thromboembolic disorders, has announced that its First-In-Human (FIH) trial confirms the early safety and feasibility of using the Bashir Endovascular Catheter for pharmaco-mechanical catheter-directed thrombolysis

       Geoff Martha, who leads Medtronic’s restorative therapies group and previously oversaw the company’s spine business, will succeed Omar Ishrak as president and CEO on April 27. Ishrak ‘s nearly 10-year tenure as chairman and CEO of Medtronic will come to an end when he retires April 26.

    Medtronic plc  and the Medtronic Foundation are committing approximately $1.2 million to coronavirus relief efforts across the globe. These contributions encompass Medtronic Foundation cash contributions and product donations from the company, according to an announcement Feb. 10.                Medtronic Foundation is partnering

  By Peggy Bush There are two types of staining that can occur when treating telangiectasia. Type I is diffuse and results from vessel wall lysis after sclerotherapy. There is red cell extravasation to the reticular dermis and iron pigment remains after red cell lysis. Type II staining occurs with

  The Venous Symposium 2020 will convene its 11th annual conference March 19-21 at the Sheraton New York Times Square Hotel, including a Latin language program. VS 2020 has scheduled 29 educational sessions, as well as an aesthetic vein course before the conference begins. In addition, VS also welcomes physicians

Vein Therapy News has added an economical new advertising opportunity to get rid of  or acquire used medical devices: “Buy or Sell Used Medical Equipment.” Physicians have asked for a forum for moving their older medical equipment that is taking up room in their offices. Publications & Communications Inc., Vein